Hypothesis: Bradykinin Blockers Might Reduce the Need for Ventilators for COVID-19 Patients

Main Article Content

Olusayo Louise- Oluwasanmi

Abstract

The symptoms of COVID-19, leading to pulmonary edema and the need for ventilators may be due to the fact that the virus increases bradykinin levels. If true, administering bradykinin blockers can provide a cheap way to reduce the severity of the symptoms and the burden on hospital resources, and, ultimately, the fatality rate.

Keywords:
ACEIs, positive feedback, pulmonary edema.

Article Details

How to Cite
Oluwasanmi, O. L.-. (2020). Hypothesis: Bradykinin Blockers Might Reduce the Need for Ventilators for COVID-19 Patients. Journal of Advances in Medicine and Medical Research, 32(12), 1-4. https://doi.org/10.9734/jammr/2020/v32i1230537
Section
Short Communication

References

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Tai Y. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respiratory Medicine. 2020;8:420–22.

Diaz JH. Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. Journal of Travel Medicine. 2020;27(3):1-2.

Biebuyck JF, Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down Regulation of Skeletal Muscle Acetylcholine Receptors Effects on Neuromuscular Blockers. Anesthesiology: The Journal of the American Society of Anesthesiologists. 1992;76(5):822-843.

Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. American Review of Respiratory Disease. 1988;137(3):613-616.

Baraniuk JN, Silver PB, Kaliner MA, Barnes PJ. Ibuprofen augments bradykinin-induced glycoconjugate secretion by human nasal mucosa in vivo. Journal of Allergy and Clinical Immuno-logy. 1992;89(5):1032-1039.

Fuller RW, Dixon CM, Cuss FM, Barnes PJ. Bradykinin-induced bronchoconstriction in humans: Mode of action. American Review of Respiratory Disease. 1987;135(1):176-180.

Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. New England Journal of Medicine. 2002;347(8): 621-622.

Hao Y, Okamura S, Wang LM, Mineshita S. The involvement of bradykinin in adrenaline-induced pulmonary edema in rats. Journal of Medical and Dental Sciences. 2001;48(3):79–85.

Craig TJ, Bernstein JA, Farkas H, Bouillet L, Boccon-Gibod I. Diagnosis and treatment of Bradykinin-mediated Angioedema: Outcomes from an angioedema expert consensus meeting. International Archives of Allergy and Immunology 2014;165(2):119-127.

Day M. Covid-19: Ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020;368: 1086.

Folkerts G, Vilieger JWD, de Vries, ANNICK, Faas S, van der Linde HENK, Engels F, Nijkamp FP. Virus-and bradykinin-induced airway hyperrespon-siveness in guinea pigs. American Journal of Respiratory and Critical Care Medicine. 2000;161(5):1666-1671.